INFINITT Healthcare Co., Ltd. (KOSDAQ:071200)
South Korea · Delayed Price · Currency is KRW 9,610.00
-310.00 (-3.13%)
At close: Sep 1, 2026
INFINITT Healthcare Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 234,258 | 142,846 | 101,040 | 126,026 | 133,827 | 174,779 | |
Market Cap Growth | 59.63% | 41.38% | -19.83% | -5.83% | -23.43% | 4.21% |
Enterprise Value | 25,067 | -22,018 | -26,082 | 32,040 | 57,145 | 108,229 |
Last Close Price | 9610.00 | 5782.49 | 4024.41 | 5019.59 | 5330.28 | 6961.41 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 3.68 | 5.41 | 2.67 | 7.66 | 1017.19 | 7.71 |
PS Ratio | 2.15 | 1.40 | 1.06 | 1.47 | 1.52 | 2.24 |
PB Ratio | 1.02 | 0.73 | 0.59 | 0.96 | 1.17 | 1.54 |
P/TBV Ratio | 1.04 | 0.75 | 0.60 | 0.97 | 1.18 | 1.56 |
P/FCF Ratio | 11.03 | 10.76 | 8.80 | 13.19 | 16.16 | 11.33 |
P/OCF Ratio | 10.93 | 10.43 | 8.55 | 12.34 | 15.29 | 10.96 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.23 | - | - | 0.37 | 0.65 | 1.39 |
EV/EBITDA Ratio | 0.96 | - | - | 4.97 | 5.49 | 11.43 |
EV/EBIT Ratio | 1.05 | - | - | 8.13 | 7.27 | 15.23 |
EV/FCF Ratio | 1.18 | - | - | 3.35 | 6.90 | 7.02 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | 0.03 |
Debt / EBITDA Ratio | 0.08 | 0.15 | 0.34 | 0.57 | 0.41 | 0.38 |
Debt / FCF Ratio | 0.10 | 0.19 | 0.30 | 0.39 | 0.51 | 0.24 |
Net Debt / Equity Ratio | -0.92 | -0.95 | -0.90 | -0.78 | -0.67 | -0.70 |
Net Debt / EBITDA Ratio | -8.17 | -11.18 | -15.18 | -16.01 | -7.39 | -8.40 |
Net Debt / FCF Ratio | -10.01 | -13.94 | -13.38 | -10.79 | -9.29 | -5.15 |
Asset Turnover | 0.42 | 0.44 | 0.49 | 0.53 | 0.60 | 0.59 |
Inventory Turnover | 28.87 | 62.59 | 28.06 | 18.89 | 20.05 | 15.48 |
Quick Ratio | 5.73 | 5.42 | 4.63 | 4.07 | 3.76 | 3.98 |
Current Ratio | 5.91 | 5.55 | 4.80 | 4.24 | 3.91 | 4.10 |
Return on Equity (ROE) | 31.56% | 14.62% | 26.80% | 14.30% | 0.14% | 22.18% |
Return on Assets (ROA) | 5.70% | 3.78% | 2.39% | 1.53% | 3.35% | 3.37% |
Return on Invested Capital (ROIC) | 120.83% | 78.43% | 27.59% | 9.73% | 21.93% | 17.03% |
Return on Capital Employed (ROCE) | 9.50% | 6.80% | 4.10% | 2.80% | 6.50% | 6.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 27.38% | 18.48% | 37.41% | 13.06% | 0.10% | 12.96% |
FCF Yield | 9.06% | 9.29% | 11.37% | 7.58% | 6.19% | 8.82% |
Payout Ratio | 7.60% | 9.23% | - | - | - | - |
Buyback Yield / Dilution | -1.12% | 0.04% | -0.04% | - | 0.19% | -0.19% |